CN118791471A - A preparation method of Besudil - Google Patents
A preparation method of Besudil Download PDFInfo
- Publication number
- CN118791471A CN118791471A CN202410783183.2A CN202410783183A CN118791471A CN 118791471 A CN118791471 A CN 118791471A CN 202410783183 A CN202410783183 A CN 202410783183A CN 118791471 A CN118791471 A CN 118791471A
- Authority
- CN
- China
- Prior art keywords
- compound
- synthesis
- added
- besudil
- dimethylformamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 36
- 230000015572 biosynthetic process Effects 0.000 claims description 21
- 238000003786 synthesis reaction Methods 0.000 claims description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 claims description 14
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims description 14
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 14
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical group ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 235000010265 sodium sulphite Nutrition 0.000 claims description 7
- XBTOSRUBOXQWBO-UHFFFAOYSA-N 1h-indazol-5-amine Chemical compound NC1=CC=C2NN=CC2=C1 XBTOSRUBOXQWBO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 229940126062 Compound A Drugs 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 20
- 238000009776 industrial production Methods 0.000 abstract description 5
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- GKHIVNAUVKXIIY-UHFFFAOYSA-N 2-[3-[4-(1h-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-n-propan-2-ylacetamide Chemical compound CC(C)NC(=O)COC1=CC=CC(C=2N=C3C=CC=CC3=C(NC=3C=C4C=NNC4=CC=3)N=2)=C1 GKHIVNAUVKXIIY-UHFFFAOYSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 2
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001263 acyl chlorides Chemical class 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000006257 total synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- PKORYTIUMAOPED-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinazoline Chemical compound C1=CC=C2NCNCC2=C1 PKORYTIUMAOPED-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical compound NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 1
- 101710092489 Protein kinase 2 Proteins 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229940074162 belumosudil Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- -1 phenol boron ester Chemical group 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical group N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- CVAWKJKISIPBOD-UHFFFAOYSA-N tert-butyl 2-bromopropanoate Chemical compound CC(Br)C(=O)OC(C)(C)C CVAWKJKISIPBOD-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及贝舒地尔,具体涉及一种贝舒地尔的制备方法。The invention relates to besudil, and in particular to a preparation method of besudil.
背景技术Background Art
贝舒地尔(Belumosudil)是一种选择性Rho相关卷曲螺旋蛋白激酶2(ROCK2)抑制剂,临床研究已证实其治疗cGVHD患者具有良好的疗效和安全性,于2021年在美国获批上市用于治疗cGVHD,目前已在加拿大、澳大利亚、英国等多个国家获批上市治疗cGVHD。其化学名为2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide,CAS登记号:911417-87-3,结构式如下所示:Belumosudil is a selective Rho-associated coiled-coil protein kinase 2 (ROCK2) inhibitor. Clinical studies have confirmed that it has good efficacy and safety in treating cGVHD patients. It was approved for marketing in the United States in 2021 for the treatment of cGVHD. It has been approved for marketing in Canada, Australia, the United Kingdom and other countries for the treatment of cGVHD. Its chemical name is 2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide, CAS registration number: 911417-87-3, and the structural formula is as follows:
经用文献检索工具Reaxys和Scifinder等检索,主要有5条路线,主要策略是其实原料和关键中间体不同,路线长短各异。After searching with literature search tools such as Reaxys and Scifinder, there are mainly 5 routes. The main strategy is that the raw materials and key intermediates are different, and the length of the routes varies.
WO2014055996和WO2015157556披露了以溴乙酰溴和丙胺为原料,经与酚硼酯亲核取代,喹唑啉发生玲木反应和脱保护得到所需产物,总计5步反应。但该路线使用了环境非友好的偶联催化剂及有毒硼酸酯和昂贵2,4-二氢喹唑啉,综合成本较高,不适用与工业化生产。WO2014055996 and WO2015157556 disclose that bromoacetyl bromide and propylamine are used as raw materials, and the desired product is obtained by nucleophilic substitution with phenol boron ester, and quinazoline undergoes Lingmu reaction and deprotection, with a total of 5 steps. However, this route uses environmentally unfriendly coupling catalysts, toxic boric esters and expensive 2,4-dihydroquinazoline, and has a high overall cost, which is not suitable for industrial production.
WO2006105081,WO2008054599,WO2010104851和WO201201040499披露了另外一条修改路线,步骤与WO2014055996前7步一致,在第8步中采用溴代丙酸叔丁酯引入乙酸基团,在通过脱保护和缩合得到目标产物。整条路线经济性相比之更差。WO2006105081, WO2008054599, WO2010104851 and WO201201040499 disclose another modified route, the steps are consistent with the first 7 steps of WO2014055996, in which tert-butyl bromopropionate is used to introduce an acetic acid group in the 8th step, and the target product is obtained by deprotection and condensation. The economic efficiency of the whole route is worse than that of the first 7 steps of WO2014055996.
WO200854599,采用酰氯为原料,以多达10步反应得到贝舒地尔,所用常用试剂过多,整体收率偏低,导致工业生产成本过高。WO200854599 uses acyl chloride as a raw material and obtains besudil through as many as 10 steps of reaction. Too many commonly used reagents are used, and the overall yield is low, resulting in excessively high industrial production costs.
Nature,2023vol.623,#7985,p.77-82揭示了一条赞新的路线,采用氧化,嘧啶化,缩合3步骤得到贝舒地尔。该路线条件苛刻,原料成本较高。所采用低温,氧化等复杂工艺,及其不利于工业化生产。Nature, 2023 vol. 623, #7985, p. 77-82 revealed a novel route to obtain besudil in three steps: oxidation, pyrimidation, and condensation. This route has harsh conditions and high raw material costs. The complex processes such as low temperature and oxidation are not conducive to industrial production.
CN106916145和WO2023/187697采用溴乙酰溴和丙胺经7步反应得到贝舒地尔,该路线条件虽不苛刻,原料来源易得,但反应步骤较长,低沸点的二氯甲烷溶剂使用过多。整条路线制备酰氯的工艺在工业放大中很不可取。CN106916145 and WO2023/187697 use bromoacetyl bromide and propylamine to obtain besudil through 7 steps. Although the conditions of this route are not harsh and the raw materials are easily available, the reaction steps are long and too much low-boiling dichloromethane solvent is used. The process of preparing acyl chloride by the whole route is not desirable in industrial scale-up.
以上专利存在技术路径存在明显的缺陷:合成路线过长,原料不易得,使用有毒或者苛刻条件,原子经济性较差,对环境很不友好。The technical paths of the above patents have obvious defects: the synthesis route is too long, the raw materials are not easy to obtain, toxic or harsh conditions are used, the atom economy is poor, and it is very unfriendly to the environment.
发明内容Summary of the invention
为克服现有技术路线缺陷,本发明提供一种制备的贝舒地尔新方法。具体技术方案如下:In order to overcome the defects of the existing technical route, the present invention provides a new method for preparing besudil. The specific technical scheme is as follows:
包括如下步骤:The steps include:
S1:化合物B的合成S1: Synthesis of Compound B
将化合物A溶于有机溶剂中,加入氯乙酸甲酯,碱,加热反应,即得化合物B;Dissolve compound A in an organic solvent, add methyl chloroacetate and a base, and heat to react to obtain compound B;
S2:化合物C的合成S2: Synthesis of Compound C
化合物B加入有机溶剂中,加入亚硫酸钠,对甲苯磺酸,加热反应,即得化合物C;Compound B is added to an organic solvent, sodium sulfite and p-toluenesulfonic acid are added, and heated to react to obtain compound C;
S3:化合物D的合成S3: Synthesis of Compound D
化合物C溶于N,N-二甲基甲酰胺中,0-5℃加入二氯亚砜反应,即得化合物D;Compound C is dissolved in N,N-dimethylformamide, and dichlorothionyl is added at 0-5°C to react to obtain compound D;
S4:化合物E的合成S4: Synthesis of Compound E
化合物D和5-氨基吲唑溶于N,N-二甲基甲酰胺中,加入N,N-二异丙基乙胺,加热反应,即得化合物ECompound D and 5-aminoindazole are dissolved in N, N-dimethylformamide, N, N-diisopropylethylamine is added, and heated to react to obtain compound E.
S5:化合物F的合成S5: Synthesis of Compound F
化合物E溶于有机溶剂中,加入异丙胺,加热反应,即得化合物F,即贝舒地尔。Compound E is dissolved in an organic solvent, isopropylamine is added, and the mixture is heated for reaction to obtain compound F, namely besudil.
进一步而言:More specifically:
步骤S1合成中所使用的溶剂为乙腈、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、丁酮、丙酮、四氢呋喃等中的一种或者几种,碱为碳酸钠、碳酸钾、碳酸铯、三乙胺、N,N-异丙基乙胺等中的一种或者几种,化合物A:氯甲酸甲酯:碱摩尔比为1:1.05~2.5:1.5~3;所属的反应温度为40-90℃。The solvent used in the synthesis of step S1 is one or more of acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, butanone, acetone, tetrahydrofuran, etc., the base is one or more of sodium carbonate, potassium carbonate, cesium carbonate, triethylamine, N,N-isopropylethylamine, etc., the molar ratio of compound A: methyl chloroformate: base is 1: 1.05-2.5: 1.5-3; the reaction temperature is 40-90°C.
所述的方法,其特征在于,The method is characterized in that
步骤S2合成中所使用的溶剂为N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二甲基亚砜一种或者几种;化合物B:亚硫酸钠:对甲苯磺酸为1:1~1.5:0.05~0.25;所属的反应温度为100-150℃。The solvent used in the synthesis of step S2 is one or more of N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, and dimethyl sulfoxide; the ratio of compound B: sodium sulfite: p-toluenesulfonic acid is 1:1-1.5:0.05-0.25; and the reaction temperature is 100-150°C.
所述的方法,其特征在于,The method is characterized in that
步骤S3合成中化合物C与二氯亚砜的的摩尔比为1:1.2~5。In the synthesis of step S3, the molar ratio of compound C to thionyl chloride is 1:1.2-5.
所述的方法,其特征在于,The method is characterized in that
步骤S4合成中化合物D:5-氨基吲唑:N,N-二异丙基乙胺的摩尔比:1:1.05~1.3:1.5~5。所述的方法,其特征在于,In the synthesis of step S4, the molar ratio of compound D: 5-aminoindazole: N, N-diisopropylethylamine is 1: 1.05-1.3: 1.5-5. The method is characterized in that:
步骤S5合成中所使用有机溶剂为异丙醇、乙醇、丁醇、二氧六环、二甲基四氢呋喃、中的一种或者几种;化合物E与异丙胺摩尔比为1:3~20;所属的反应温度为60-120℃。The organic solvent used in the synthesis of step S5 is one or more of isopropanol, ethanol, butanol, dioxane, dimethyltetrahydrofuran, etc.; the molar ratio of compound E to isopropylamine is 1:3-20; and the reaction temperature is 60-120°C.
有益效果:Beneficial effects:
1.总合成步骤为5步,明显优于文献报道路线,总合成收率60%(以2-氨基乙醛计);1. The total synthesis steps are 5 steps, which is significantly better than the route reported in the literature, and the total synthesis yield is 60% (based on 2-aminoacetaldehyde);
2.原料价格低廉,来源广泛,操作简单,反应条件温和,所用试剂为常用试剂,试剂均环境友好,极大地降低了对人体及环境的危害。2. The raw materials are cheap, widely available, simple to operate, and have mild reaction conditions. The reagents used are commonly used reagents, and all the reagents are environmentally friendly, which greatly reduces the harm to the human body and the environment.
3.原料选择的好,基团一直贯穿到整个反应,成本降低,化合物B和C关环氧化工艺特殊,且克服特高温反应条件。3. The raw materials are well selected, the groups run through the entire reaction, the cost is reduced, the epoxidation process of compounds B and C is special, and the ultra-high temperature reaction conditions are overcome.
4.本工艺路线原子经济性较好,特别适合于工业生产,能在较短时间大批量产生贝舒地尔。4. This process route has good atom economy and is particularly suitable for industrial production, and can produce besudil in large quantities in a short time.
具体实施方式DETAILED DESCRIPTION
为了使本发明的目的、技术方案及优点更加清楚明白,以下具体实施例对本发明进行进一步详细说明。本发明中的实验方法,如无特殊说明,均为常规方法。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。In order to make the purpose, technical scheme and advantages of the present invention clearer, the following specific examples further describe the present invention in detail. The experimental methods in the present invention are conventional methods unless otherwise specified. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
本发明的反应进程可采用本领域中的常规监测方法(例如TLC、HPLC或NMR)进行监测,一般以原料消失时为反应终点。The progress of the reaction of the present invention can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the disappearance of the starting material is generally regarded as the reaction endpoint.
实施例1:提供了一种化合物B的制备方法,其合成路线如下:Example 1: A method for preparing compound B is provided, and its synthetic route is as follows:
具体采用如下方法制备:The specific preparation method is as follows:
氮气气氛中,将化合物A(50g,409mmol)溶于乙腈(0.5L)中,加入碳酸钾(113g,819mmol)搅拌30min氯乙酸甲酯(53.3g,491mmol),加热至80℃回流反应6h,TLC监控原料至消失过滤浓缩回收溶剂即得产物,采用本方法制备得到无色油状物,72g,收率:92%,纯度:96.3%。In a nitrogen atmosphere, compound A (50 g, 409 mmol) was dissolved in acetonitrile (0.5 L), potassium carbonate (113 g, 819 mmol) was added, and methyl chloroacetate (53.3 g, 491 mmol) was stirred for 30 min. The mixture was heated to 80 ° C and refluxed for 6 h. The raw material was monitored by TLC until it disappeared, filtered, concentrated, and the solvent was recovered to obtain the product. The method was used to prepare a colorless oil, 72 g, with a yield of 92% and a purity of 96.3%.
对本实施例中制得的中间体II进行鉴定,得到如下结果:The intermediate II obtained in this example was identified to obtain the following results:
ESI-MS(m/z):194.19;ESI-MS (m/z): 194.19;
1H NMR(400MHz,CDCl3)δppm 10.02(s,1H),7.53(m,1H)7.49(t,J=7.8Hz,1H),7.37(dd,J=2.8,1.6Hz,1H)7.24(ddd,J=8.8,2.8,1.6Hz,1H),4.74(s,2H),3.85(s,3H)。1H NMR (400MHz, CDCl3) δppm 10.02 (s, 1H), 7.53 (m, 1H) 7.49 (t, J=7.8Hz, 1H), 7.37 (dd, J=2.8, 1.6Hz, 1H) 7.24 (ddd, J=8.8, 2.8, 1.6Hz, 1H), 4.74 (s, 2H), 3.85 (s, 3H).
实施例2:提供了一种化合物C的制备方法,其合成路线如下:Example 2: A method for preparing compound C is provided, and its synthetic route is as follows:
具体采用如下方法制备:化合物B:亚硫酸钠:对甲苯磺酸为1:1:1The specific preparation method is as follows: Compound B: sodium sulfite: p-toluenesulfonic acid in a ratio of 1:1:1
将化合物B(150g,772mmol)和氨基苯甲酰胺(105g,772mmol)溶于N,N-二甲基乙酰胺(1.25L)中,加入亚硫酸钠(80.4g,772mmol),对甲苯磺酸(10g,58mmol,加热至120℃反应16h,HPLC监控至原料及中间态消失后,降至室温,导入7L水中,充分搅拌后过滤,滤饼烘干后,用乙酸乙酯/石油醚(200ml/400ml)打浆,即得化合物C。Compound B (150 g, 772 mmol) and aminobenzamide (105 g, 772 mmol) were dissolved in N, N-dimethylacetamide (1.25 L), and sodium sulfite (80.4 g, 772 mmol) and p-toluenesulfonic acid (10 g, 58 mmol) were added. The mixture was heated to 120 °C for 16 h. After HPLC monitoring until the raw material and the intermediate disappeared, the mixture was cooled to room temperature and introduced into 7 L of water. After sufficient stirring, the mixture was filtered. After the filter cake was dried, it was slurried with ethyl acetate/petroleum ether (200 ml/400 ml) to obtain compound C.
采用本方法制备得到白色固体184g,收率:77%,纯度:95.2%。The method was used to prepare 184 g of a white solid with a yield of 77% and a purity of 95.2%.
ESI-MS(m/z):310.10;ESI-MS (m/z): 310.10;
1H NMR(400MHz,DMSO),12.52(s,1H),8.16(d,J=8.0,1H),7.90-7.80(m,2H),7.80-7.70(m,2H),7.54(t,1H),7.48(t,1H),7.18(dd,J=8.0,J=4.0,1H),4.95(s,2H),3.75(s,3H)。 1 H NMR (400MHz, DMSO), 12.52 (s, 1H), 8.16 (d, J=8.0, 1H), 7.90-7.80 (m, 2H), 7.80-7.70 (m, 2H), 7.54 (t, 1H ), 7.48 (t, 1H), 7.18 (dd, J=8.0, J=4.0, 1H), 4.95 (s, 2H), 3.75 (s, 3H).
实施例3:提供了一种化合物D的制备方法:Example 3: A method for preparing compound D is provided:
化合物C(31.0g,0.1mol)溶于N,N-二甲基甲酰胺(150ml)中,于0-5℃滴入二氯亚砜(35.7g,0.3mol),滴毕后逐渐升至室温反应2h。TLC监控至原料反应完毕后导入冰水中淬灭,充分搅拌后,过滤后即得化合物D;Compound C (31.0 g, 0.1 mol) was dissolved in N, N-dimethylformamide (150 ml), and thionyl chloride (35.7 g, 0.3 mol) was added dropwise at 0-5°C. After the addition, the temperature was gradually raised to room temperature for 2 hours. After TLC monitoring, the reaction of the raw material was completed and then introduced into ice water for quenching. After sufficient stirring, the compound D was obtained after filtration.
采用本方法制备得到白色固体33g,收率:100%,纯度:95.4%。The method was used to prepare 33 g of a white solid with a yield of 100% and a purity of 95.4%.
ESI-MS(m/z):328.75ESI-MS(m/z):328.75
1H NMR(400MHz,DMSO),8.18(d,J=8.0,1H),7.90(dt,1H),7.85-7.80(m,2H),7.78-7.72(m,2H),7.57(t,1H),7.50(t,1H),7.20(dd,J=8.0,J=4.0,1H),4.95(s,2H),3.75(s,3H)。 1 H NMR (400MHz, DMSO), 8.18 (d, J=8.0, 1H), 7.90 (dt, 1H), 7.85-7.80 (m, 2H), 7.78-7.72 (m, 2H), 7.57 (t, 1H ), 7.50 (t, 1H), 7.20 (dd, J=8.0, J=4.0, 1H), 4.95 (s, 2H), 3.75 (s, 3H).
实施例4:提供了一种化合物E的制备方法:Example 4: A method for preparing compound E is provided:
化合物D(33.0g,0.100mol),5-氨基吲唑(14.0g,0.105mmol),N,N-二异丙基乙胺(38.9g,0.301mol)溶于N,N-二甲基甲酰胺(0.5L)中,氮气气氛中,加热至120℃反应8h,TLC监控至原料反应完毕后,倒入水中淬灭,二氯甲烷(100ml)打浆,即得化合物E。Compound D (33.0 g, 0.100 mol), 5-aminoindazole (14.0 g, 0.105 mmol), and N,N-diisopropylethylamine (38.9 g, 0.301 mol) were dissolved in N,N-dimethylformamide (0.5 L) and heated to 120 °C in a nitrogen atmosphere for 8 h. After TLC monitoring until the reaction of the raw materials was completed, the mixture was poured into water for quenching and slurried with dichloromethane (100 ml) to obtain compound E.
采用本方法制备得到白色固体38g,收率:89%,纯度:96.1%。The method was used to prepare 38 g of a white solid with a yield of 89% and a purity of 96.1%.
ESI-MS(m/z):425.15;ESI-MS (m/z): 425.15;
1H NMR(400MHz,DMSO)δ13.11(s,1H),9.98(s,1H),8.59(d,J=8.0,1H),8.26(s, 1 H NMR (400MHz, DMSO) δ13.11 (s, 1H), 9.98 (s, 1H), 8.59 (d, J=8.0, 1H), 8.26 (s,
1H),8.14(s,1H),8.06(dd,J=8.0,1H),8.00-7.92(m,1H),7.90-7.80(m,3H),7.70-7.55(m,1H), 8.14 (s, 1H), 8.06 (dd, J=8.0, 1H), 8.00-7.92 (m, 1H), 7.90-7.80 (m, 3H), 7.70-7.55 (m,
2H),7.40(t,1H),7.06(t,1H),4.88(s,2H),3.65(s,3H)。2H), 7.40(t, 1H), 7.06(t, 1H), 4.88(s, 2H), 3.65(s, 3H).
实施例5:提供了一种化合物F(贝舒地尔)制备方法:Example 5: A method for preparing compound F (besudildil) is provided:
化合物E(17.0g,44.0mmol)溶于异丙醇中(170ml),加入异丙胺(23.6g,0.400mol)加热至75℃密封反应3h。TLC监控至原料反应完毕降至室温后,浓缩除掉溶剂。乙酸乙酯(100ml)打浆即得化合物F。Compound E (17.0 g, 44.0 mmol) was dissolved in isopropanol (170 ml), and isopropylamine (23.6 g, 0.400 mol) was added and heated to 75°C and sealed for reaction for 3 h. After TLC monitoring, the raw material reaction was completed and cooled to room temperature, and then the solvent was removed by concentration. Ethyl acetate (100 ml) was slurried to obtain compound F.
采用本方法制备得到淡黄色固体17g,收率:94%,纯度:99.2%。The method was used to prepare 17 g of a light yellow solid with a yield of 94% and a purity of 99.2%.
ESI-MS(m/z):452.52;ESI-MS (m/z): 452.52;
1H NMR(400MHz,DMSO)δ13.02(s,1H),8.52(dd,J=4.0,1H),8.25(s,1H), 1 H NMR (400MHz, DMSO) δ13.02 (s, 1H), 8.52 (dd, J=4.0, 1H), 8.25 (s, 1H),
8.09(s,1H),7.99(s,1H),7.96(dd,J=4.0,1H),7.85(dd,J=4.0,1H),7.82-7.74(m,8.09 (s, 1H), 7.99 (s, 1H), 7.96 (dd, J=4.0, 1H), 7.85 (dd, J=4.0, 1H), 7.82-7.74 (m,
3H),7.65-7.45(m,2H),7.35(t,1H),7.02(d,J=4.0,1H),4.45(s,3H),4.00-3.84(m,3H), 7.65-7.45(m, 2H), 7.35(t, 1H), 7.02(d, J=4.0, 1H), 4.45(s, 3H), 4.00-3.84(m,
1H),1.04(d,J=4.0,6H)。1H), 1.04 (d, J=4.0, 6H).
实施例6提供了一种化合物B的制备方法,其合成路线如下:Example 6 provides a method for preparing compound B, and its synthetic route is as follows:
具体采用如下方法制备:The specific preparation method is as follows:
氮气气氛中,将化合物A(50g,409mmol)溶于N,N-二甲基甲酰胺(0.5L)中,加入碳酸钾(113g,819mmol)搅拌30min氯乙酸甲酯(53.3g,491mmol),加热至70℃回流反应8h,TLC监控原料至消失过滤,浓缩回收溶剂即得产物,采用本方法制备得到无色油状物,72g,收率:87%,纯度:95.1%。In a nitrogen atmosphere, compound A (50 g, 409 mmol) was dissolved in N, N-dimethylformamide (0.5 L), potassium carbonate (113 g, 819 mmol) was added, and methyl chloroacetate (53.3 g, 491 mmol) was stirred for 30 min. The mixture was heated to 70 ° C and refluxed for 8 h. The raw material was monitored by TLC until it disappeared and filtered. The solvent was concentrated and recovered to obtain the product. The method was used to prepare a colorless oil, 72 g, with a yield of 87% and a purity of 95.1%.
实施例7:提供了一种化合物C的制备方法,其合成路线如下:Example 7: A method for preparing compound C is provided, and its synthetic route is as follows:
具体采用如下方法制备:The specific preparation method is as follows:
将化合物I(150g,772mmol)和氨基苯甲酰胺(105g,772mmol)溶于N,N-二甲基乙酰胺(1.25L)中,加入亚硫酸钠(121g,1.16mol),对甲苯磺酸(20g,116mmol,加热至120℃反应8h,HPLC监控至原料及中间态消失后,降至室温,导入7L水中,充分搅拌后过滤,滤饼烘干后,用乙酸乙酯/石油醚(200ml/400ml)打浆,即得化合物C。Compound I (150 g, 772 mmol) and aminobenzamide (105 g, 772 mmol) were dissolved in N, N-dimethylacetamide (1.25 L), and sodium sulfite (121 g, 1.16 mol) and p-toluenesulfonic acid (20 g, 116 mmol) were added. The mixture was heated to 120 °C and reacted for 8 h. After HPLC monitoring until the raw material and the intermediate disappeared, the mixture was cooled to room temperature and introduced into 7 L of water. After sufficient stirring, the mixture was filtered. After the filter cake was dried, it was slurried with ethyl acetate/petroleum ether (200 ml/400 ml) to obtain compound C.
采用本方法制备得到白色固体123g,收率:51%,纯度:96.7%。The method was used to prepare 123 g of a white solid with a yield of 51% and a purity of 96.7%.
实施例8:提供了一种化合物D的制备方法:Example 8: A method for preparing compound D is provided:
化合物C(31.0g,0.099mol)溶于N,N-二甲基甲酰胺(150ml)中,于0-5°滴入二氯亚砜(11.9g,0.198mol),滴毕后逐渐升至室温反应2h。TLC监控至原料停止后倒入冰水中淬灭,充分搅拌后,过滤,甲叔醚打浆(100ml)后即得化合物D。Compound C (31.0 g, 0.099 mol) was dissolved in N, N-dimethylformamide (150 ml), and thionyl chloride (11.9 g, 0.198 mol) was added dropwise at 0-5°. After the addition, the temperature was gradually raised to room temperature and reacted for 2 h. After TLC monitoring until the raw material stopped, it was poured into ice water for quenching, stirred thoroughly, filtered, and slurried with tert-methyl ether (100 ml) to obtain compound D.
采用本方法制备得到白色固体28g,收率:85%,纯度:97.8%。The method was used to prepare 28 g of a white solid with a yield of 85% and a purity of 97.8%.
实施例9:提供了一种化合物E的制备方法:Example 9: A method for preparing compound E is provided:
化合物D(33.0g,0.100mol),5-氨基吲唑(14.0g,0.105mmol),N,N-二异丙基乙胺(25.9g,0.200mol)溶于N,N-二甲基甲酰胺(0.5L)中,氮气气氛中,加热至120℃反应8h,TLC监控至原料反应完毕后,倒入水中淬灭,二氯甲烷(100ml)打浆,即得化合物E。Compound D (33.0 g, 0.100 mol), 5-aminoindazole (14.0 g, 0.105 mmol), and N,N-diisopropylethylamine (25.9 g, 0.200 mol) were dissolved in N,N-dimethylformamide (0.5 L) and heated to 120 °C in a nitrogen atmosphere for 8 h. After TLC monitoring until the reaction of the raw materials was completed, the mixture was poured into water for quenching and slurried with dichloromethane (100 ml) to obtain compound E.
采用本方法制备得到白色固体33g,收率:87%,纯度:96.3%。The method was used to prepare 33 g of a white solid with a yield of 87% and a purity of 96.3%.
实施例10:提供了一种化合物F(贝舒地尔)制备方法:Example 10: A method for preparing compound F (besudildil) is provided:
化合物E(17.0g,44.0mmol)溶于2-二氧六环中(170ml),加入异丙胺(23.6g,0.400mol)加热至90℃密封反应2h。TLC监控至原料反应完毕降至室温后,浓缩除掉溶剂。乙酸乙酯(100ml)打浆即得化合物F。Compound E (17.0 g, 44.0 mmol) was dissolved in 2-dioxane (170 ml), and isopropylamine (23.6 g, 0.400 mol) was added and heated to 90°C in a sealed container for 2 h. After TLC monitoring, the raw material reaction was completed and the temperature dropped to room temperature, and then the solvent was removed by concentration. Ethyl acetate (100 ml) was used for slurrying to obtain compound F.
采用本方法制备得到淡黄色固体16g,收率:88%,纯度:98.5%。The method was used to prepare 16 g of a light yellow solid with a yield of 88% and a purity of 98.5%.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410783183.2A CN118791471A (en) | 2024-06-18 | 2024-06-18 | A preparation method of Besudil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410783183.2A CN118791471A (en) | 2024-06-18 | 2024-06-18 | A preparation method of Besudil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118791471A true CN118791471A (en) | 2024-10-18 |
Family
ID=93023098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410783183.2A Pending CN118791471A (en) | 2024-06-18 | 2024-06-18 | A preparation method of Besudil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118791471A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119751424A (en) * | 2025-01-04 | 2025-04-04 | 重庆圣华曦药业股份有限公司 | A new method for synthesizing besudil mesylate |
-
2024
- 2024-06-18 CN CN202410783183.2A patent/CN118791471A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119751424A (en) * | 2025-01-04 | 2025-04-04 | 重庆圣华曦药业股份有限公司 | A new method for synthesizing besudil mesylate |
| CN119751424B (en) * | 2025-01-04 | 2025-12-05 | 重庆圣华曦药业股份有限公司 | A method for synthesizing besudil mesylate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101337930B (en) | The preparation method of urea derivative | |
| CN108424388B (en) | A kind of preparation method of chronic anemia medicine | |
| CN102356063B (en) | Method for preparing 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthylcarboxamide and its synthesis intermediate | |
| US11465970B2 (en) | Method for synthesis of Roxadustat and intermediate compounds thereof | |
| KR20100017101A (en) | Process for the preparation of gefitinib | |
| JP2010209071A (en) | Process for preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline | |
| CN110028489A (en) | A kind of method that decompression method prepares benzamide compound | |
| CN118791471A (en) | A preparation method of Besudil | |
| CN117794567A (en) | Method for the preparation of pure 2-nitro-4-methylsulfonylbenzoic acid | |
| TW564246B (en) | 3-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation thereof and the use thereof | |
| CN102659629B (en) | Compound and application thereof in preparing erlotinib | |
| KR100720220B1 (en) | Process for preparing substituted aniline compound | |
| WO2025140615A1 (en) | Method for preparing deucravacitinib and intermediates thereof | |
| WO2002006228A1 (en) | Process for producing 5-fluorooxyindole and for producing intermediate therefor | |
| KR20040039430A (en) | Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor | |
| CN112028906A (en) | A kind of "one-pot cooking method" prepares pinoxaden method | |
| Kumaraswamy et al. | An expeditious, practical large scale synthesis of 4-amino-2-chloro-6, 7-dimethoxyquinazolinazoline | |
| Sepideh et al. | Pd-Catalyzed Carbonylation-cyclization of N′-(2-bromophenyl) benzamidines by Chloroform as a CO Precursor for the Synthesis of Quinazolin-4 (3 H)-ones | |
| CN111039838A (en) | Preparation method of 3-acetylmercapto-2-methylpropanoic acid | |
| CA2502360C (en) | Process for producing acetylene compound | |
| CN114957112B (en) | (2-Chloroquinolin-3-yl) methyl (N-p-fluorophenyl) carbamate and its preparation method and application | |
| CN113336780B (en) | Preparation method of 2-formyl-4- (4-cyanophenoxy) phenylboronic acid pinacol ester | |
| WO2018028665A1 (en) | Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as mek inhibitor | |
| CN115572264B (en) | A method for preparing enzalutamide | |
| CN102050766A (en) | Synthesis method for amosulalol hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |